404
Penicillin Market Report
Global Penicillin Market, Trends, Dynamics, and Market Analysis
The report on the Global Penicillin Market is segmented By Drug Class (Natural Penicillin, Aminopenicillin, Beta-lactamase Inhibitors, Penicillinase-Resistant Penicillin, Anti-Pseudomonal Penicillin), Route of Administration (Oral, Intravenous, Intramuscular), Application (Urinary Tract Infections, Sexually Transmitted Diseases, Meningitis, Respiratory Tract Infections, Skin Infections, Others), Distribution Channel (...
Pfizer, Inc (The U.S), Sanofi S.A. (France), Toyama Chemical Co., Ltd. (Japan), Novartis International AG (Switzerland), GlaxoSmithKline plc (UK), Merck & Co., Inc. (The U.S), Astellas Pharma Inc. (Japan), Johnson & Johnson (The U.S), Bayer AG (Germany), Abbott Laboratories (The U.S) and F. Hoffmann-La Roche AG (Switzerland) are among the key players in the penicillin market.
North America accounted for the largest share of penicillin market in 2020.
The hospital pharmacies segment accounted for the largest share of penicillin market in 2020.
Increasing number of people suffering from infectious diseases such as pneumonia, syphilis, and gonorrhoea, growing emphasis on organizing awareness campaigns by both private companies and government to control bacterial infectious diseases are the factors driving the growth of penicillin market.
Penicillin manufacturers, Penicillin suppliers, Penicillin distributors, Organizations, Government bodies are the target audience in the penicillin market.